Brief: Granules Receives US FDA Eir With Voluntary Action Indicated For Chantilly Facility
03/06/2026 11:02
BRIEF-Granules Receives US FDA Eir With Voluntary Action Indicated For Chantilly Facility June 3 (Reuters) - Granules India Ltd GRAN.NS:
GRANULES - RECEIVES US FDA EIR WITH VOLUNTARY ACTION INDICATED FOR CHANTILLY FACILITY
GRANULES - FOUR FORM 483 OBSERVATIONS ISSUED DURING MARCH 30-APRIL 3, 2026 INSPECTION
Source text: ID:nNSE2qnM0s
Further company coverage: GRAN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Granules India
See all newsBrief: Granules Receives US FDA Eir With Voluntary Action Indicated For Chantilly Facility
India's Granules jumps on Q4 profit growth
Granules India hits record high on Q4 profit, revenue jump
Granules India's fourth-quarter profit jumps on strong demand
Brief: Granules India Q4 Consol Profit 2.02 Billion Rupees